OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
5.21
-0.01 (-0.19%)
Apr 29, 2026, 11:31 AM EDT - Market open
OnKure Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 210 | 39 | 115 | - | - |
| Market Cap Growth | 430.99% | -65.75% | - | - | - |
| Enterprise Value | 152 | -30 | 243 | - | - |
| Last Close Price | 5.22 | 2.90 | 8.60 | - | - |
| PB Ratio | 1.27 | 0.70 | 1.11 | - | - |
| P/TBV Ratio | 3.75 | 0.70 | 1.11 | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 |
| Net Debt / Equity Ratio | -1.04 | -1.04 | -1.06 | -1.04 | -1.09 |
| Net Debt / EBITDA Ratio | 0.94 | 0.94 | 2.07 | 0.80 | 0.37 |
| Net Debt / FCF Ratio | 1.13 | 1.13 | 2.14 | 0.84 | 0.39 |
| Quick Ratio | 9.97 | 9.97 | 10.52 | 4.10 | 2.08 |
| Current Ratio | 10.28 | 10.28 | 10.73 | 4.64 | 2.46 |
| Return on Equity (ROE) | -74.39% | -74.39% | -79.92% | -186.07% | - |
| Return on Assets (ROA) | -44.45% | -44.45% | -44.43% | -89.24% | - |
| Return on Capital Employed (ROCE) | -112.00% | -112.00% | -51.30% | -129.80% | -284.70% |
| Earnings Yield | -28.23% | -151.48% | -45.91% | - | - |
| FCF Yield | -24.60% | -132.03% | -44.60% | - | - |
| Buyback Yield / Dilution | -292.10% | -292.10% | -1114.54% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.